Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: GUERBET
Woman and Man Max 99 years
GUERBET
Update Il y a 4 ans
Study to evaluate the product flow, breakdown and elimination of DOTAREM from the blood and its safety and efficacy in children aged > 2 years
To evaluate pharmacokinetics profile in plasma of DOTAREM following single intravenous injection in pediatric subjects aged up to 23 months (inclusive)
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GUERBET
Update Il y a 4 ans
A RANDOMIZED DOUBLE-BLIND PARALLELL GROUP CLINICAL STUDY OF XENETIX 300 VERSUS VISIPAQUE 270 IN MULTISLICE CT PEDIATRIC INDICATIONS
To demonstrate the equivalence of Xenetix 300 and Visipaque 270 in terms of renal tolerance when injected for MSCT in pediatric indications
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GUERBET
Update Il y a 4 ans
Intra-individual efficacy evaluation of DOTAREM®-enhanced MRA compared to GADOVIST®–enhanced MRA in the diagnosis of clinically significant abdominal or limb arterial diseases
To assess the clinical equivalence of the diagnostic performance of DOTAREM®-enhanced MRA as compared to GADOVIST® - enhanced MRA by comparing the arterial visualization of vessels from the abdominal ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GUERBET
Update Il y a 4 ans
Diagnostic contribution of XENETIX® CT PERFUSION in pre-therapeutical assessment of hepatocellular carcinoma
To prospectively determine the diagnostic value of Xenetix®-CT perfusion for the discrimination between well-differentiated HCC and moderately/poorly differentiated HCC (off-site assessment). Histopat...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
GUERBET
Update Il y a 4 ans
Etude GDX-44-008 : étude de preuve de concept relative à l’efficacité du P03277 dans l’imagerie par résonance magnétique pour le diagnostic du carcinome hépatocellulaire. [essai clos aux inclusions]
Le carcinome hépatocellulaire (CHC) est le cancer primitif du foie le plus fréquent. Il reste très longtemps asymptomatique et donc de diagnostic tardif. La détection précoce permettrait d’administrer...
Country
France
organs
Primitif du foie
Specialty
Imagerie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
GUERBET
Update Il y a 4 ans
Xenetix 350: comparative assesment of Image quality for coronary CT Angiography
To demonstrate the statistical non-inferiority of Xenetix 350 compared to Ultravist 370 and Iomeron 400 when used in coronary angiography in terms of CT scan evaluability (quality and interpretability...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
GUERBET
Update Il y a 5 ans
Etude GDX-44-008 : étude de preuve de concept relative à l’efficacité du P03277 dans l’imagerie par résonance magnétique pour le diagnostic du carcinome hépatocellulaire.
Le carcinome hépatocellulaire (CHC) est le cancer primitif du foie le plus fréquent. Il reste très longtemps asymptomatique et donc de diagnostic tardif. La détection précoce permettrait d’administrer...
Country
France
organs
Primitif du foie
Specialty
Imagerie
Essai ouvert aux inclusions
More information
Woman and Man Max 99 years
GUERBET
Update Il y a 4 ans
SAFETY AND EFFICACY EVALUATION OF DOTAREM® IN MAGNETIC RESONANCE IMAGING (MRI) IN PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) LESIONS
To demonstrate the superiority of Dotarem®-enhanced MRI as compared to unenhanced MRI in CNS (intracranial and spine) lesions in terms of lesion visualization (lesion border delineation, visualization...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GUERBET
Update Il y a 4 ans
EVALUACIÓN DE LA SEGURIDAD RENAL TRAS ARM POTENCIADA CON DOTAREM EN COMPARACIÓN CON LA RM SIN CONTRASTE ENTRE PACIENTES CON ALTO RIESGO DE PADECER NEFROPATIA PROVOCADA POR EL MEDIO DE CONTRASTE RENAL SAFETY EVALUATION AFTER DOTAREM-ENHANCED MRA COMPARED WITH NON-ENHANCED MRI IN PATIENTS AT HIGH RISK OF DEVELOPING CONTRAST MEDIUM INDUCED NEPHROPATHY
Evaluar, entre pacientes de riesgo (aquejados al menos de insuficiencia renal moderada) la frecuencia de la nefropatía provocada por contraste tras someterse a ARM realzada con Dotarem, en comparación...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
GUERBET
Update Il y a 4 ans
Efficacy evaluation of DOTAREM®-enhanced MRA compared to GADOVIST®–enhanced MRA in the diagnosis of clinically significant abdominal or lower limb arterial diseases
To demonstrate the clinical equivalence (statistical non-inferiority) in terms of global diagnostic performance of DOTAREM®-enhanced MRA as compared to GADOVIST® - enhanced MRA by comparing the degree...
Country
None
organs
None
Specialty
None
unknown
More information
1
2
Next